← Leaderboards
Andreas S Bommarius
Georgia Institute Of Technology
$3,064,658
Attributed
$6,154,155
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2018–25$2.5M$1.9M$1.3M$625K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,119,330 · 1
FDA$2,034,825 · 1
By mechanism
RF1$4,119,330 · 1
U01$2,034,825 · 1
Top collaborators
- Bo Liang2 shared
- David G Lynn2 shared
- Zhexing Wen2 shared
Most similar at Georgia Institute Of Technology
Same institution · by research overlap
- Gregory C. Gibson$7,991,905
- Gang Bao$62,962,213
- Yury O Chernoff$2,725,138
- Nicole Marie Baran$118,240
- Zachary V Johnson$966,103
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposChromatinAtac-SeqAlpha SynucleinAgedCharacteristicsAmino AcidsAmino Acid SequenceAmyloidAmyloid Beta-ProteinCerebrumAmyloid Beta-Protein PrecursorAmericanAreaAgingBiochemicalBiological ModelsBrainBrain TissueCell ModelCell NucleusCell TypeAbeta AccumulationCryoelectron Microscopy
Grant awards (5)
Understanding the functional impacts of Aβ variants in Alzheimer's disease with human brain organoids$1,785,477
RF1 · FY2025 · AG
Understanding the functional impacts of Aβ variants in Alzheimer's disease with human brain organoids$2,333,853
RF1 · FY2022 · AG
Continuous synthesis, crystallization, and isolation (CSCI) of an API: process model-controlled enzymatic synthesis of beta-lactam antibiotics$472,319
U01 · FY2020 · FD · contact PI
Continuous synthesis, crystallization, and isolation (CSCI) of an API: process model-controlled enzymatic synthesis of beta-lactam antibiotics$579,637
U01 · FY2019 · FD · contact PI
Continuous synthesis, crystallization, and isolation (CSCI) of an API: process model-controlled enzymatic synthesis of beta-lactam antibiotics$982,869
U01 · FY2018 · FD · contact PI